Abstract
Background: Men affected by liver cirrhosis frequently show clinical features of hypogonadism due to hormonal changes, in particular in the metabolism of 17β-estradiol (E2) and testosterone (T). Sex hormone-binding globulin (SHBG), the major binding protein of these steroids in serum, is regularly elevated in such patients, with its androgen-binding properties possibly altered. In the present study, surface plasmon resonance biosensor techniques were used to determine whether the functional binding properties of this transporter are maintained in this pathology.
Methods: We selected 33 male patients with cirrhosis, Child-Pugh grade A or B, and 32 healthy males served as controls. Serum concentrations of T, E2, dehydroepiandrosterone sulfate (DHEAS) and SHBG were measured. In addition, ligand-binding properties of SHBG partially purified from sera of 23 cirrhotic patients and 20 controls were analyzed by a real-time biosensor technique using a surface-coated dihydrotestosterone derivative.
Results: The sensorgrams revealed that SHBG was fully bioactive in all samples investigated without any changes in binding kinetics. Moreover, total T concentrations were not significantly different in the cirrhotic patient sera (mean±SD 18.0±8.6nmol/L) compared to controls (15.6±3.7; n.s.), whereas E2 was higher (152±60 vs. 96±29pmol/L; p<0.0001) and DHEAS was lower (1493±1410 vs. 5099±2844 nmol/L; p<0.0001).
Conclusions: Owing to elevated SHBG levels without changes in the steroid-binding properties in sera of cirrhotic male patients, free or bioavailable T concentrations are lower. This causes a shift of the hormonal balance in favor of E2, which exhibits a lower affinity for SHBG than androgens and accounts for the endocrine symptoms.
Clin Chem Lab Med 2006;44:967–73.
References
1. Johnson PJ. Sex hormones and liver. Clin Sci 1984; 66:369–76.10.1042/cs0660369Search in Google Scholar
2. Longcope C, Pratt JH, Schneider S, Fineberg E. Estrogen and androgen dynamics in liver disease. J Endocrinol Invest 1984; 7:629–33.10.1007/BF03349497Search in Google Scholar
3. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005; 152:501–13.10.1530/eje.1.01886Search in Google Scholar
4. Tanaka K, Sakai H, Hashizume M, Hirohata T. Serum testosterone/estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res 2000; 60:5106–10.Search in Google Scholar
5. Nolte W, Schindler CG, Figulla HR, Wuttke W, Hufner M, Hartmann H, et al. Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt. J Hepatol 2001; 34:818–24.10.1016/S0168-8278(01)00052-6Search in Google Scholar
6. Bannister P, Losowsky MS. Sex hormones and chronic liver disease. J Hepatol 1988; 6:258–62.10.1016/S0168-8278(88)80039-4Search in Google Scholar
7. Van Thiel DH, Gavaler JS, Spero JA, Egler KM, Wright C, Sanghvi AT, et al. Patterns of hypothalamic-pituitary-gonadal dysfunction in men with liver disease due to differing etiologies. Hepatology 1981; 1:39–46.10.1002/hep.1840010107Search in Google Scholar
8. De Besi L, Zucchetta P, Zotti S, Mastrogiacomo I. Sex hormones and sex hormone binding globulin in males with compensated and decompensated cirrhosis of the liver. Acta Endocrinol (Copenh) 1989; 120:271–6.10.1530/acta.0.1200271Search in Google Scholar
9. Iturriaga H, Lioi X, Valladares L. Sex hormone-binding globulin in non-cirrhotic alcoholic patients during early withdrawal and after longer abstinence. Alcohol Alcohol 1999; 34:903–9.10.1093/alcalc/34.6.903Search in Google Scholar
10. Terasaki T, Nowlin DM, Pardridge WM. Differential binding of testosterone and estradiol to isoforms of sex-hormone-binding globulin: selective alteration of estradiol binding in cirrhosis. J Clin Endocrinol Metab 1988; 67:639–43.10.1210/jcem-67-4-639Search in Google Scholar
11. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 1974; 3:69–96.10.1111/j.1365-2265.1974.tb03298.xSearch in Google Scholar
12. Hammond GL. Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocr Rev 1990; 11:65–79.10.1210/edrv-11-1-65Search in Google Scholar
13. Westphal U. Steroid-protein interactions II. Monogr Endocrinol 1986; 27:198–264.10.1007/978-3-642-82486-9_7Search in Google Scholar
14. Petra PH. The plasma sex steroid binding protein (SBP or SHBG). A critical review of recent developments on the structure, molecular biology and function. J Steroid Biochem Mol Biol 1991; 40:735–53.10.1016/0960-0760(91)90299-KSearch in Google Scholar
15. Joseph DR. Structure, function, and regulation of androgen-binding protein/sex hormone-binding globulin. Vitam Horm 1994; 49:197–280.10.1016/S0083-6729(08)61148-6Search in Google Scholar
16. Vermeulen AL, Verdonck L, Van der Straeten M, Orie M. Capacity of the testosterone binding globulin in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol Metab 1969; 29:1470–80.10.1210/jcem-29-11-1470Search in Google Scholar
17. Petra PH, Stanczyk FZ, Namkung PC, Fritz MA, Novy MJ. Direct effect of sex steroid-binding protein (SBP) of plasma on the metabolic clearance rate of testosterone in the rhesus macaque. J Steroid Biochem 1985; 22:739–46.10.1016/0022-4731(85)90280-8Search in Google Scholar
18. Plymate SR, Namkung PC, Metej LA, Petra PH. Direct effect of plasma sex hormone binding globulin (SHBG) on the metabolic clearance rate of 17β-estradiol in the primate. J Steroid Biochem 1990; 36:311–7.10.1016/0022-4731(90)90223-FSearch in Google Scholar
19. Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005; 122:751–62.10.1016/j.cell.2005.06.032Search in Google Scholar
20. Burke CW, Anderson DC. Sex-hormone-binding globulin is an oestrogen amplifier. Nature 1972; 240:38–40.10.1038/240038a0Search in Google Scholar
21. Jönsson U, Malmqvist M. Real time biospecific interaction analysis, the integration of surface plasmon resonance detection, general biospecific interface chemistry and microfluidics into one analytical system. Adv Biosensors 1992; 2:291–336.Search in Google Scholar
22. Hauptmann H, Metzger J, Schnitzbauer A, Cuilleron CY, Mappus E, Luppa PB. Syntheses and ligand-binding studies of 1α- and 17α-amino-alkyl dihydrotestosterone derivatives to human sex hormone-binding globulin. Steroids 2003; 68:629–39.10.1016/S0039-128X(03)00092-8Search in Google Scholar
23. Metzger J, Schnitzbauer A, Meyer M, Söder M, Cuilleron CY, Luppa PB. Binding analysis of 1α- and 17α-dihydrotestosterone derivatives to homodimeric sex hormone-binding globulin. Biochemistry 2003; 42:13735–45.10.1021/bi035269kSearch in Google Scholar
24. Thaler M, Metzger J, Schreiegg A, Denk B, Gleixner A, Hauptmann H, et al. Immunoassay for sex hormone-binding globulin in undiluted serum is influenced by high-molecular-mass aggregates. Clin Chem 2005; 51:401–7.10.1373/clinchem.2004.034264Search in Google Scholar
25. Selby C. Sex hormone-binding globulin: origin, function and clinical significance. Ann Clin Biochem 1990; 27:532–41.10.1177/000456329002700603Search in Google Scholar
26. Kaymakoglu S, Ökten A, Cakaloglu Y, Boztas G, Besisik F, Tascioglu C, et al. Hypogonadism is not related to the etiology of liver cirrhosis. J Gastroenterol 1995; 30:745–50.10.1007/BF02349641Search in Google Scholar
27. Gravel P, Walzer C, Aubry C, Balant LP, Yersin B, Hoch-strasser DF, et al. New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. Biochem Biophys Res Commun 1996; 220:78–85.10.1006/bbrc.1996.0360Search in Google Scholar
28. Valladares L, Erices A, Lioi X, Iturriaga H. Characterization of the oligosaccharides of plasma sex hormone binding globulin from noncirrhotic alcoholic patients. Steroids 2000; 65:275–80.10.1016/S0039-128X(00)00086-6Search in Google Scholar
29. Baker HW, Burger HG, de Kretser DM, Dulmanis A, Hudson B, O'Connor S, et al. A study of the endocrine manifestations of hepatic cirrhosis. Q J Med 1976; 45:145–78.Search in Google Scholar
30. Kley HK, Nieschlag E, Wiegelmann W, Solbach HC, Krüskemper HL. Steroid hormones and their binding in plasma of male patients with fatty liver, chronic hepatitis and liver cirrhosis. Acta Endocrinol (Copenh) 1975; 72:275–85.10.1530/acta.0.0790275Search in Google Scholar
31. Gordon GG, Olivo J, Rafii F, Southren AL. Conversion of androgens to estrogens in cirrhosis of the liver. J Clin Endrocrinol Metab 1975; 40:1018–26.10.1210/jcem-40-6-1018Search in Google Scholar
32. Leowattana W. DHEAS as a new diagnostic tool. Clin Chim Acta 2004; 341:1–15.10.1016/j.cccn.2003.10.031Search in Google Scholar
33. Amory JK, Bremner W. Endocrine regulation of testicular function in men: implications for contraceptive development. Mol Cell Endocrinol 2001; 182:175–9.10.1016/S0303-7207(01)00562-7Search in Google Scholar
34. Tilbrook AJ, Clarke IJ. Negative feedback regulation of the secretion and actions of gonadotropin-releasing hormone in males. Biol Reprod 2001; 64:735–42.10.1095/biolreprod64.3.735Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York